This session explores how the rapid rise of GLP-1 medications is fundamentally reshaping away-from-home eating and what that means for research chefs and menu innovators. Drawing from Mattson’s proprietary multi-phase study of GLP-1 users and other market data, the presentation uncovers dramatic shifts in appetite, taste perception, protein and fiber needs, alcohol consumption, and restaurant visitation. Attendees will gain data-backed insights and concept-tested menu ideas designed to meet emerging nutritional and sensory demands. With up to 35% of future food & beverage sales potentially influenced by GLP-1 users, this session challenges operators to rethink portioning, nutrient density, and menu architecture for a rapidly evolving consumer landscape.

CEUs Eligible: 1 CEU 

Speakers

  • Katie Hagan (Chief Innovation Officer, Mattson)
  • Erin McGlothlin (Mattson)

Resources00:45:00

Course Details

© Copyright 2026 |

Terms | Privacy | Culinology.org | Designed by Boldare